2023/0491 - LANADELUMAB [300 MG/2 ML SOL INJ SERINGA]
TED · 394155-2026can-standardawardedNo deadline given
Buyer
NameUnidade Local de Saúde Santa Maria, E.P.E.
CountryPT
Published2026-06-09
Deadline—
Value
Estimated€700,776 · 700,775.68 EUR
Awarded—
WinnerTAKEDA-Farmaceuticos Portugal, Lda
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
LANADELUMAB [300 MG/2 ML SOL INJ SERINGA]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-09 | 2023/0491 - SECUCINUMAB [300 MG/2 ML SOL INJ CANETA/ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-09 | 2023/0491 - SECUCINUMAB [300 MG/2 ML SOL INJ CANETA/ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-02 | 2023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-02 | 2023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
Records136,978 tendersNewest notice2026-06-24Last ingest2026-06-25 · TED daily 06:00Parser health (7d)all runs clean